Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03751995 · ClinicalTrials.gov registry record · NA

POEM (Practice of Embracing Each Moment) Study (Delivery Science)

A NA study, sponsored by Kaiser Permanente.

Completed
Registry status
NA
Development phase
142
Enrollment target

NCT03751995: Completed NA study, sponsored by Kaiser Permanente.

NCT03751995 is a NA study that has completed, run by Kaiser Permanente. The registered enrollment target is 142 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (90% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03751995, a NA study, has completed, sponsored by Kaiser Permanente.

COMPLETED
Registry status
NA
Development phase
142 participants
Enrollment target

Study Summary

The objective of the proposed pilot pragmatic cluster randomized trial targeting cancer patients undergoing palliative and supportive therapy and their informal caregivers is to pilot test implementation of mHealth two mindfulness interventions as part of standard palliative care support within Kaiser Permanente Northern California.

Primary Outcome

The 14-item Hospital Anxiety and Depression Scale (HADS) assesses anxiety and depression. Each subscale (depression and anxiety) is scored from 0 to 21 by summing individual item scores, with higher scores indicating greater anxiety and depression; 0-7 is generally considered within normal range.

Interventions

  • BEHAVIORAL Mindfulness meditation

Trial Details

FieldValue
Enrollment Target 142 participants
Start Date 2018-10-31
Est. Completion 2020-04-29
Phase NA
Kaiser Permanente

294 total trials

What the finished NCT03751995 record still lists

NCT03751995 is an interventional study that assigns participants to a tested intervention. The registered 142 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (90% lower).

The record links to 0 conditions, and to 1 intervention - of which Mindfulness meditation is the first listed.

NCT03751995 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03751995 about?

NCT03751995 is a clinical study titled "POEM (Practice of Embracing Each Moment) Study (Delivery Science)". The objective of the proposed pilot pragmatic cluster randomized trial targeting cancer patients undergoing palliative and supportive therapy and their informal caregivers is to pilot test implementation of mHealth two mindfulness interventions as part of standard palliative care support within Kais...

What is the current status of trial NCT03751995?

This trial is currently completed. It is a NA study. The enrollment target is 142 participants. The study started on 2018-10-31. Estimated completion is 2020-04-29.

What interventions are being tested in trial NCT03751995?

The interventions under investigation include: Mindfulness meditation (BEHAVIORAL).

Who is sponsoring clinical trial NCT03751995?

This trial is sponsored by Kaiser Permanente, which has 294 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03751995's enrollment target sits among peer trials

142 711th of 2000 higher than 1,289 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03933631 · 142 participants · Phase 3

    Pilocarpine Use After Kahook Goniotomy

  • NCT04938349 · 142 participants · NA

    Dual Task Perturbation Training for OAwMCI

  • NCT06117254 · 142 participants · NA

    Hearing Aids for Veterans With Functional Hearing Difficulties

  • NCT06463665 · 142 participants · Phase 2

    Efficacy & Safety of Olvimulogene Nanivacirepvec & Platinum-doublet + Physician's Choice of Immune Checkpoint Inhibitor Compared to Docetaxel in NSCL Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03751995, the US trial registry maintained by the National Library of Medicine. NCT03751995 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.